Clariscope

Explore package inserts against the NIOSH hazardous-drug criteria.

Reading a stack of package inserts shouldn’t take a lost afternoon. Clariscope gives you instant access to the manufacturer’s labeling as published in DailyMed, and checks any drug against the NIOSH List of Hazardous Drugs, 2024, showing you the exact label language in seconds. Informational only: it supports your facility’s own review and is not a hazard determination.

Start exploring
0
drugs on the NIOSH List, 2024, checked against every name you screen
0
Table 1 antineoplastics, typically the focus of the strictest USP <800> handling controls
0
Table 2 drugs eligible for a documented Assessment of Risk
0
of entries backed by the live FDA package insert of record

How it works

Built on the sources you already trust.

Clariscope doesn’t invent hazard calls. It brings together the same authoritative sources your team already relies on and shows you the exact label language behind every finding, so the professional judgment stays yours with less of the manual work.

01

Authoritative sources

Every drug is checked against the NIOSH List of Hazardous Drugs, 2024 and its current FDA package insert of record, the primary references USP <800> points to. Nothing is guessed or made up.

02

The label language, shown

For each drug you see the exact label language behind the finding: the special-handling wording and the toxicity signals NIOSH looks for, cited so your qualified staff can verify it and sign off. The determination stays with your team.

03

Read it your way

Open the manufacturer’s PDF insert inline, compare label versions to see what changed over time, or get a plain-language AI reading of the label. Whatever helps your team understand the drug fastest.

Product tour

See Clariscope in action

Watch a drug list checked against its manufacturer labeling and the NIOSH List of Hazardous Drugs, 2024, screened by NDC or name.

Screen your drugs

Explore any drug’s package insert and NIOSH status.

Look up any drug against the NIOSH List of Hazardous Drugs, 2024 and its FDA package insert: screen by NDC or drug name, browse the full NIOSH list, read the cited label language, and open an AI reading of any insert. No account needed.

1 Drug names or NDCs
Names or NDCs, mixed freely — one per line, comma-separated, or a CSV export with an NDC or Drug column (other columns are ignored).
Recent NIOSH label changes

Track label changes on NIOSH-listed drugs

Every drug on this timeline is on the NIOSH List of Hazardous Drugs, 2024 and had its FDA package insert revised in the window below. Clariscope tracks all 236, so you can see recent label activity at a glance. Informational only: a revision may or may not affect handling, and this view is not a complete record of every change. The monthly email calls out the ones that look handling-relevant.

147
NIOSH drugs updated
158
label revisions
60 · 87
Table 1 · Table 2
6 months
window
Mar 18Jun 16Sep 14
T1
5 revisions · Aug 31
T2
3 revisions · Sep 2
T2
2 revisions · Aug 31
T2
2 revisions · Sep 10
T2
2 revisions · Aug 31
T1
2 revisions · Sep 10
T2
2 revisions · Aug 24
T2
1 revision · Sep 7
T2Divalproex
1 revision · Aug 24
T2Estradiol
1 revision · Sep 2
+ 139 more NIOSH drugs updated in the last 6 months
Snapshot generated Sep 14, 2026, from openFDA label-revision dates cross-referenced with the NIOSH List of Hazardous Drugs, 2024. A revision date marks a new FDA label version; it is not a hazard determination.

Good to know

Questions compliance leads ask first.

No. Clariscope is an information tool: it screens every drug, gathers the NIOSH List status and the special-handling and toxicity language from the package insert, and shows you the cited text. Everything else stays with your team: your qualified staff review the label language and make every determination under your own policies. Clariscope informs that work. It doesn’t advise on it, doesn’t make determinations, and isn’t a substitute for your facility’s own USP <800> program. A “not found” result does not mean that a drug is non-hazardous or that no special handling requirements apply.
Yes — and you don’t have to choose. Names and NDCs go in the same box, mixed freely: one per line, comma-separated, or a CSV export with an NDC or Drug column. An NDC names one product, so it is screened straight away. A drug name usually matches many, so the screener shows every matching FDA product first — each with its manufacturer, dosage form and NDC — and you pick the ones you want, filtering by manufacturer or form and sorting the list to find them. Both routes give the same package-insert read.
Clariscope saves nothing to a server. You look drugs up and the results stay in your browser (only your display preferences are kept, on your device). The drug names and NDC codes you screen are sent to the FDA openFDA API and DailyMed (NLM/NIH) to retrieve the matching package inserts, and (only when you choose to) to the AI reader. There are no accounts, so there’s nothing to sign in to.
Two things: the NIOSH List of Hazardous Drugs, 2024 (all 236 drugs, Tables 1 & 2) for list status, and each drug’s current FDA package insert, read for the manufacturer’s special-handling information and the toxicity signals in the NIOSH definition.
It scans the insert against the seven NIOSH hazardous-drug criteria (2024): manufacturer special-handling information (cytotoxic, antineoplastic, “special handling”), carcinogenicity, genotoxicity/mutagenicity, developmental/teratogenicity, reproductive/fertility toxicity, organ toxicity (flagged to verify at low/therapeutic doses), and drug-class/mechanism hints (e.g. antibody-drug conjugate, alkylating agent) for comparison against known hazardous drugs. It shows the exact sentences it found, and sets aside statements that are negated (“was not mutagenic”, “studies have not been conducted”), reported only in animals, or that name a test or a disease rather than a finding about the drug — listing them separately so you can review them yourself. You can also open an AI reading of the insert for a plain-language, cited walkthrough.
Some repackaged, compounded, or very new products don’t have a current FDA insert on file. Those rows are marked “No label found”. Try the code with or without its final package segment (e.g. 0338-9777 vs 0338-9777-01), or try the generic name. A “not found” result does not mean that a drug is non-hazardous or that no special handling requirements apply.